John C. Lechleiter
2016
In 2016, John C. Lechleiter earned a total compensation of $18.4M as Chairman, President, and Chief Executive Officer at Lilly Eli & Co, a 11% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $3,144,633 |
|---|---|
| Non-Equity Incentive Plan | $2,632,500 |
| Salary | $1,500,000 |
| Stock Awards | $11,000,000 |
| Other | $90,000 |
| Total | $18,367,133 |
Lechleiter received $11M in stock awards, accounting for 60% of the total pay in 2016.
Lechleiter also received $3.1M of change in pension value and nonqualified deferred compensation earnings, $2.6M in non-equity incentive plan, $1.5M in salary and $90K in other compensation.
Rankings
In 2016, John C. Lechleiter's compensation ranked 150th out of 14,075 executives tracked by ExecPay. In other words, Lechleiter earned more than 98.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 150 out of 14,075 | 99th |
Division Manufacturing | 46 out of 5,488 | 99th |
Major group Chemicals And Allied Products | 13 out of 1,900 | 99th |
Industry group Drugs | 11 out of 1,543 | 99th |
Industry Pharmaceutical Preparations | 10 out of 1,173 | 99th |
Source: SEC filing on March 20, 2017.
Lechleiter's colleagues
We found four more compensation records of executives who worked with John C. Lechleiter at Lilly Eli & Co in 2016.
2016
Derica Rice
Lilly Eli & Co
Chief Financial Officer
2016
Jan Lundberg
Lilly Eli & Co
Executive Vice President, Science and Technology, and President, Lilly Research Laboratories
2016
Michael Harrington
Lilly Eli & Co
General Counsel
2016
Enrique Conterno
Lilly Eli & Co